Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-assisted pattern recognition of autoantibody results.

Steven R Binder1, Mark C Genovese, Joan T Merrill

  • 1Bio-Rad Laboratories, 4000 Alfred Nobel Drive, Hercules, CA 94547, USA. steve_binder@bio-rad.com

Clinical and Diagnostic Laboratory Immunology
|December 13, 2005
PubMed
Summary

A new multiplex immunoassay with a kNN algorithm improves anti-nuclear antibody (ANA) screening by identifying systemic lupus erythematosus (SLE) patterns, aiding in specialist referrals and reducing unnecessary evaluations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adiposity-Associated Monocyte Costimulatory Programming in Rheumatoid Arthritis Identified by Single-Cell Transcriptomics.

medRxiv : the preprint server for health sciences·2026
Same author

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.

JAMA dermatology·2026
Same author

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Journal of clinical epidemiology·2026

Area of Science:

  • * Clinical immunology and autoimmune disease diagnostics.
  • * Development of computational algorithms for medical pattern recognition.

Background:

  • * Current immunoassay-based anti-nuclear antibody (ANA) screening lacks pattern information crucial for guiding further diagnostic steps.
  • * Indirect fluorescence assay (IFA) provides pattern data but is less amenable to automation than immunoassays.

Purpose of the Study:

  • * To evaluate a novel multiplex immunoassay combined with a k-nearest neighbor (kNN) algorithm for computer-assisted ANA pattern recognition.
  • * To enhance the diagnostic utility of immunoassay-based ANA screening by providing pattern information.

Main Methods:

  • * A training set of 1,152 sera from patients with rheumatic diseases and healthy individuals was used.
  • * A test set of 173 sera from a rheumatology clinic and 152 healthy controls was evaluated using the multiplex immunoassay, kNN algorithm, and HEp-2 cell-based ELISA.

Related Experiment Videos

  • * Clinical sensitivity and specificity were assessed for the multiplex method and algorithm.

    • Main Results:

    • * The multiplex immunoassay and ELISA showed 94% positivity for systemic lupus erythematosus (SLE) patients.
    • * The kNN algorithm correctly identified SLE patterns in 84% of antibody-positive SLE patients.
    • * The multiplex method yielded fewer positive results than ELISA in non-connective tissue disease patients, with the kNN algorithm not proposing disease for most.

    Conclusions:

    • * The automated kNN algorithm can effectively identify SLE patterns from multiplex immunoassay data.
    • * This approach may assist in identifying patients who require early specialist referral.
    • * The method could also help in excluding patients who do not need further autoimmune disease evaluation.